RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
. Brain natriuretic peptide modulates calcium homeostasis and epidermal growth factor receptor gene signalling in asthmatic airways smooth muscle cells.
2015 Orlandi, A; Calzetta, L; Doldo, E; Tarquini, C; Matera, Maria Gabriella; Passeri, D.
1. New developments in the combination treatment of COPD: focus on umeclidinium/vilanterol.
2013 Cazzola, M; Segreti, A; Matera, Maria Gabriella
10. Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary disease.
2013 Cazzola, M; Rogliani, P; Matera, Maria Gabriella
5-HT modifiers as a potential treatment of asthma
2000 Cazzola, I; Matera, Maria Gabriella
[The therapeutic prospects of ischemic cardiopathy]
1994 Rossi, Francesco; Matera, Maria Gabriella; Filippelli, A; Giasi, M; Fici, F.
A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease
1996 Matera, Maria Gabriella; Caputi, M; Cazzola, M.
A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease
1998 Cazzola, M; Matera, Maria Gabriella; DI PERNA, F; Calderaro, F; Califano, C; Vinciguerra, A.
A comparison of sensory nerve function in human, guinea-pig, rabbit and marmoset airways
1998 Spina, D; Matera, Maria Gabriella; Riccio, Mm; Page, Cp
A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease
1995 Matera, Maria Gabriella; Cazzola, M; Vinciguerra, A; DI PERNA, F; Calderaro, F; Caputi, M; Rossi, Francesco
A long-term clinical trial on the efficacy and safety profile of doxofylline in Asthma: The LESDA study
2020 Calzetta, L.; Matera, M. G.; Goldstein, M. F.; Fairweather, W. R.; Howard, W. W.; Cazzola, M.; Rogliani, P.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 340
- 1 Contributo su Rivista::1.1 Arti... 340
Data di pubblicazione
- 2020 - 2023 45
- 2010 - 2019 170
- 2000 - 2009 54
- 1990 - 1999 62
- 1982 - 1989 7
Editore
- Academic Press 2
- ACADEMIC PRESS LTD- ELSEVIER SCIE... 1
Rivista
- PULMONARY PHARMACOLOGY & THERAPEU... 47
- RESPIRATORY MEDICINE 38
- EXPERT OPINION ON PHARMACOTHERAPY 16
- EXPERT REVIEW OF RESPIRATORY MEDI... 14
- CHEST 11
- DRUGS 9
- EXPERT OPINION ON DRUG METABOLISM... 9
- CURRENT OPINION IN PHARMACOLOGY 8
- EUROPEAN JOURNAL OF PHARMACOLOGY 7
- LIFE SCIENCES 7
Keyword
- Humans 47
- COPD 44
- Asthma 38
- Pulmonary and Respiratory Medicine 33
- Pulmonary Disease 25
- Chronic Obstructive 24
- Pharmacology (medical) 24
- Pharmacology 19
- Bronchodilator Agents 17
- Lung 12
Lingua
- eng 283
- ita 2
Accesso al fulltext
- no fulltext 340